Distal esophageal reflux accompanies nocturnal gastric acid breakthrough in patients with gastroesophageal reflux disease (GERD) on proton pump inhibitor (PPI) bid.

被引：3
|
作者：
Anderson, C [1 ]
Katz, P [1 ]
Khoury, R [1 ]
Castell, D [1 ]
机构：
[1] Allegheny Univ Hosp, Philadelphia, PA USA
来源：
GASTROENTEROLOGY | 1998年 / 114卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(98)80229-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G0229
引用
收藏
页码：A56 / A57
页数：2
相关论文
共 50 条
  • [31] Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors
    Katz, PO
    Anderson, C
    Khoury, R
    Castell, DO
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (12) : 1231 - 1234
  • [32] Gastroesophageal Reflux Disease Symptom Severity, Proton Pump Inhibitor Use, and Esophageal Carcinogenesis
    Nason, Katie S.
    Wichienkuer, Promporn Paula
    Awais, Omar
    Schuchert, Matthew J.
    Luketich, James D.
    O'Rourke, Robert W.
    Hunter, John G.
    Morris, Cynthia D.
    Jobe, Blair A.
    [J]. ARCHIVES OF SURGERY, 2011, 146 (07) : 851 - 858
  • [33] Role of Acid and Weakly Acidic Reflux in Gastroesophageal Reflux Disease Off Proton Pump Inhibitor Therapy
    Sung, Hea Jung
    Cho, Yu Kyung
    Moon, Sung Jin
    Kim, Jin Su
    Lim, Chul Hyun
    Park, Jae Myung
    Lee, In Seok
    Kim, Sang Woo
    Choi, Myung-Gye
    [J]. JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 18 (03) : 291 - 297
  • [34] Unresolved upper gastrointestinal (UGI) and extraesophageal (EE) symptoms in gastroesophageal reflux disease (GERD) patients despite chronic proton pump inhibitor (PPI) therapy
    Earnest, D
    Lembo, A
    Novick, J
    Proskin, H
    Rojavin, M
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S48 - S49
  • [35] Nocturnal acid breakthrough and esophageal acidification during treatment with dexlansoprazole as compared to omeprazole in patients with gastroesophageal reflux disease
    Ghoshal, Uday C.
    Blaachandran, Arjun
    Rai, Sushmita
    Misra, Asha
    [J]. INDIAN JOURNAL OF GASTROENTEROLOGY, 2022, 41 (04) : 405 - 414
  • [36] Healthcare utilization and cost in pediatric gastroesophageal reflux disease (GERD) patients on continuous vs. intermittent proton pump inhibitor (PPI) treatment regimens
    Nelson, Suzanne P.
    Kothari, Smita
    Wu, Eric Q.
    Persson, Bjorn
    Beaulieu, Nicolas
    Arana, Mateo
    Lu, Mei
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S450 - S450
  • [37] Nocturnal acid breakthrough and esophageal acidification during treatment with dexlansoprazole as compared to omeprazole in patients with gastroesophageal reflux disease
    Uday C. Ghoshal
    Arjun Blaachandran
    Sushmita Rai
    Asha Misra
    [J]. Indian Journal of Gastroenterology, 2022, 41 : 405 - 414
  • [38] Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease
    Yadlapati, Rena
    Delay, Kelli
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2019, 103 (01) : 15 - +
  • [39] The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease
    Pace, Fabio
    Pace, Marina
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (04) : 423 - 427
  • [40] Prospective Evaluation of Duodenogastroesophageal Reflux in Gastroesophageal Reflux Disease Patients Refractory to Proton Pump Inhibitor Therapy
    Kunsch, S.
    Neesse, A.
    Linhart, T.
    Nell, C.
    Gress, T. M.
    Ellenrieder, V.
    [J]. DIGESTION, 2012, 86 (04) : 315 - 322
12345